Anti-CCR9 CAR-T Cells for T Acute Lymphoblastic Leukemia

被引：2
|
作者：
Maciocia, Paul M. [1 ]
Wawrzyniecka, Patrycja [1 ]
Maciocia, Nicola C. [1 ]
Burley, Amy [1 ]
O'Connor, David [1 ]
Leon, Theresa E. [1 ]
Rapoz-D'Silva, Tanya [1 ]
Karpanasamy, Thaneswari [1 ]
Pule, Martin [1 ]
Mansour, Marc R. [1 ,2 ]
机构：
[1] UCL, Inst Canc, London, England
[2] Great Ormond St Inst Child Hlth, London, England
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146565
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
903
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, Jiang
    Wang, Gang
    Cheng, Hai
    Wei, Chen
    Qi, Kunming
    Sang, Wei
    Li Zhenyu
    Shi, Ming
    Li, Huizhong
    Qiao, Jianlin
    Pan, Bin
    Zhao, Jing
    Wu, Qingyun
    Zeng, Lingyu
    Niu, Mingshan
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 851 - 858
  • [22] Treating Acute Leukemia with CAR-T cell and antibodies
    Ehninger, Gerhard
    BONE MARROW TRANSPLANTATION, 2018, 53 : 813 - 813
  • [23] CAR-T CELL THERAPY FOR ACUTE MYELOID LEUKEMIA
    Nakazawa, Yozo
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S7 - S7
  • [24] Optimizing CAR-T cell therapy in adults with B-cell acute lymphoblastic leukemia
    Agrawal, Vaibhav
    Murphy, Lindsey
    Pourhassan, Hoda
    Pullarkat, Vinod
    Aldoss, Ibrahim
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 236 - 247
  • [25] CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease
    Pehlivan, Katherine C.
    Duncan, Brynn B.
    Lee, Daniel W.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (05) : 396 - 406
  • [26] QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING OF BISPECIFIC ANTIBODIES AND CAR-T IN ACUTE LYMPHOBLASTIC LEUKEMIA.
    Demin, O., Jr.
    Nikitich, A.
    Demin, O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S64 - S64
  • [27] Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis
    Di Majo, Benedetta E.
    Vendemini, Francesca
    Bonanomi, Sonia
    Casartelli, Pietro
    Napolitano, Sara
    Ottaviano, Giorgio
    Prunotto, Giulia
    Verna, Marta
    Sala, Alessandra
    Migliorino, Guglielmo M.
    Petrella, Francesco
    Rosso, Lorenzo
    Claut, Laura
    Raviele, Paola Rafaniello
    Rizzari, Carmelo
    Biondi, Andrea
    Balduzzi, Adriana
    Lucchini, Giovanna
    TUMORI JOURNAL, 2024,
  • [28] CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease
    Katherine C. Pehlivan
    Brynn B. Duncan
    Daniel W. Lee
    Current Hematologic Malignancy Reports, 2018, 13 : 396 - 406
  • [29] CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?
    Damiani, Daniela
    Tiribelli, Mario
    BIOMEDICINES, 2024, 12 (06)
  • [30] In vitro studies on the transfer of CAR into leukemia cells due to their residue in the autologous CAR-T cell preparation system for acute B-cell acute lymphoblastic leukemia
    刘美静
    China Medical Abstracts(Internal Medicine), 2021, 38 (02) : 117 - 118
12345